The Effect of External Diaphragmatic Pacemaker on the Patients With Chronic Cor Pulmonale
1 other identifier
interventional
50
1 country
1
Brief Summary
This study evaluates the effect of external diaphragmatic pacemaker on the patients with chronic cor pulmonale. Half of participants will receive external diaphragmatic pacemaker, while the other half will receive routine therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 8, 2016
CompletedFirst Posted
Study publicly available on registry
November 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedOctober 23, 2017
November 1, 2016
6 months
November 8, 2016
October 20, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
cardiopulmonary function
six miunte walk test
10 days
Secondary Outcomes (1)
MIP
10 DAYS
Study Arms (2)
external diaphragmatic pacemaker group
EXPERIMENTALuse the external diaphragmatic pacemakerI 9 counts per minute, with stimulate frequency 40 Hz
control group
NO INTERVENTIONNo inervention, just receive conventional therapy
Interventions
9 counts per minute, with stimulate frequency 40 Hz
Eligibility Criteria
You may qualify if:
- diagnosis of chronic cor pulmonale and admit to hospital
You may not qualify if:
- pneumothorax or mediastinal emphysema
- active tuberculosis
- install a cardiac pacemaker
- acute cardiocerebrovascular events: acute myocardial infarction, acute myocarditis, severe arrhythmia, severe cerebrovascular accidents.
- pregnancies
- end-stage patients (expected survival time less than 6 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhang Xiangyulead
Study Sites (1)
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, 200072, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
xiangyu zhang, doctor
Tongji University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Intensive care medicine
Study Record Dates
First Submitted
November 8, 2016
First Posted
November 29, 2016
Study Start
November 1, 2016
Primary Completion
May 1, 2017
Study Completion
August 1, 2017
Last Updated
October 23, 2017
Record last verified: 2016-11